Immunotherapy

Open Access
New Approaches in Targeted Therapy for Medulloblastoma in Children
HENRIETTA MAIER, TINA DALIANIS and OURANIA N. KOSTOPOULOU

Anticancer Research April 2021, 41 (4) 1715-1726; DOI: https://doi.org/10.21873/anticanres.14936
You have access
Impact of Renin–angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
TAKEHIRO TOZUKA, NORIKO YANAGITANI, HIROSHI YOSHIDA, RYO MANABE, SHINSUKE OGUSU, RYOSUKE TSUGITOMI, HIROAKI SAKAMOTO, YOSHIAKI AMINO, RYO ARIYASU, KEN UCHIBORI, SATORU KITAZONO, MASAHIRO SEIKE, AKIHIKO GEMMA and MAKOTO NISHIO

Anticancer Research April 2021, 41 (4) 2093-2100; DOI: https://doi.org/10.21873/anticanres.14980
You have access
Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy
YUDAI ISHIYAMA, TSUNENORI KONDO, YUKI NEMOTO, YUKI KOBARI, HIROKI ISHIHARA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, YASUNOBU HASHIMOTO, TOSHIO TAKAGI, JUNPEI IIZUKA and KAZUNARI TANABE

Anticancer Research March 2021, 41 (3) 1607-1614; DOI: https://doi.org/10.21873/anticanres.14922
You have access
Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer
MAX R. CLEVERS, ELISABETH A. KASTELIJN, BAS J.M. PETERS, HANS KELDER and FRANZ M.N.H. SCHRAMEL

Anticancer Research February 2021, 41 (2) 869-876; DOI: https://doi.org/10.21873/anticanres.14839
You have access
Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options
EVA KATHARINA EGGER, MATTHIAS B. STOPE, FLORIAN RECKER, DOMINIQUE KONSGEN, JENNIFER LANDSBERG, ANNE FROHLICH, ALINA ABRAMIAN and ALEXANDER MUSTEA

Anticancer Research February 2021, 41 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.14854
You have access
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications
KATHRINE S. RALLIS, THOMAS HO LAI YAU and MICHAIL SIDERIS

Anticancer Research January 2021, 41 (1) 1-7; DOI: https://doi.org/10.21873/anticanres.14746
You have access
Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells
JOSEPH D. MALAER and PORUNELLOOR A. MATHEW

Anticancer Research December 2020, 40 (12) 6613-6621; DOI: https://doi.org/10.21873/anticanres.14686
You have access
Differential Analyses of Peripheral Blood Parameters in CCR5 Inhibition-treated Colorectal Cancer Patients Reveal Dynamic Changes Linked to Clinical Outcomes
AZAZ AHMED and NIELS HALAMA

Anticancer Research December 2020, 40 (12) 6933-6939; DOI: https://doi.org/10.21873/anticanres.14717
You have access
Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial
KOICHI MITSUYA, YASUTO AKIYAMA, AKIRA IIZUKA, HARUO MIYATA, SHOICHI DEGUCHI, NAKAMASA HAYASHI, CHIE MAEDA, RYOTA KONDOU, AKARI KANEMATSU, KYOKO WATANABE, TADASHI ASHIZAWA, YOSHIAKI ABE, ICHIRO ITO, TAKUMA OISHI, TAKASHI SUGINO, YOKO NAKASU and KEN YAMAGUCHI

Anticancer Research November 2020, 40 (11) 6473-6484; DOI: https://doi.org/10.21873/anticanres.14669
You have access
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents
Y. MAURICE MORILLON, ARIANA SABZEVARI, JEFFREY SCHLOM and JOHN W. GREINER

Anticancer Research October 2020, 40 (10) 5329-5341; DOI: https://doi.org/10.21873/anticanres.14540

Main menu

User menu

Search

Immunotherapy

Pages